VUNO 로고

VUNO Med®-DeepBrain™

Why Quantitative Brain MRI

Accelerate MRI
Diagnostics
for
Dementia

Accurately Diagnosing Dementia
Poses a Significant Challenge

MRI is utilized for diagnosing and classifying
dementia. 1, 2
Different and subtle atrophy
patterns and vascular
burdens characterize
diagnosed dementia subtypes,
making accurate
diagnosis challenging. 3 Particularly,
unskilled
physicians face greater difficulties in this regard. 4

Gain Insights about
different kinds of dementias

Quantitative volumetric tools for brain MRI studies
offer valuable information about a variety of
dementias,
enabling radiologists to enhance the
value of MRI
while reducing subjectivity. 5

New Alzheimer's Therapies
Necessitate Expanded
MRI Analysis

Monoclonal antibodies are emerging disease-
modifying
therapies for Alzheimer’s disease that
require brain MR
imaging for eligibility
assessment as well as for
monitoring for
amyloid-related imaging abnormalities,
which
may greatly increase neuroradiology practice
volumes. 6

Brain MRI volumetry
improves clinical
diagnosis in
various
neurological diseases

Brain volumetry using MRI
can aid
diagnosis and monitoring
of a
variety of neurodegenerative
diseases. 7

Quantitative volumetric postprocessing tools for
brain MRI
studies offer valuable adjunctive
information through
baseline analysis and
longitudinal tracking of a variety of
neurologic
conditions, including dementia, MS, traumatic
brain injury, neuro-oncology, and epilepsy. The
novel
information provided can assist radiologists
and enhance
the value of MRI while reducing
subjectivity. 8

Brain MRI volumetry is helpful
in the identification of early
disease
progression among
MS patients

The estimated prevalence of MS patients is around
2.8 million people worldwide. In recent years,
brain
atrophy measurement using MRI has been
proposed
as a promising marker of tissue damage
and
neurodegeneration among MS patients. 9

Brain volumetry is frequently
used
to assist in clinical diagnosis
of
suspected hippocampal sclerosis
in temporal lobe epilepsy. 10

From 1999 to 2017, epilepsy mortality rates in the
USA
increased 98.8%, from 5.83 per million in
1999 to 11.59
per million2. Volumetric estimates
of hippocampal size
are postulated to be more
sensitive than visual
assessment alone, and also
to improve clinical diagnosis
in dementia and
epilepsy. 11